Source: Annual Congress 2001 - Inhalation technology and respiratory measurement in disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. A. Carter, S. L. Hill (Birmingham, United Kingdom). Assessment of bronchodilator reversibility in patients with bronchiectasis (BE). Eur Respir J 2001; 16: Suppl. 31, 906

Member's Comments

No comment yet.

Related content which might interest you: Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Bronchodilator responsiveness in patients with COPD Source: Eur Respir J 2008; 31: 742-750 Year: 2008 Hemodynamic effects of inhaled fenoterol and ipratropium in patients with obstructive pulmonary diseases Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 Evaluation of vibration response imaging (VRI) in COPD and asthma patients before and after bronchodilators Source: Eur Respir J 2007; 30: Suppl. 51, 100s Year: 2007 Bronchodilator reversibility (BDR) - should we measure it in adults with symptoms but without obstructed spirometry? Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities Year: 2021 Effect of inhaled bronchodilator therapy on the bacterioexcretion and on the quality of life (LQ) of pulmonary TB patients with concomitant lung obstructive syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006 Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002 The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008 Influence of tiotropium bromid on airway inflammation and symptom in COPD patients Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Efficacy and tolerability of budesonide/formoterol (B/F) added to tiotropium (T) vs T alone in East-Asian patients (pts) with severe/very severe chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Evaluation of inhalant deposition of ICS/LABA in the peripheral airway of asthma patients using Functional Respiratory Imaging (FRI) Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Treatment effect of inhaled prolonged bronchodilator therapy (IPBT) combined with inhaled glucocorticosteroids (IGCS) on respiratory symptoms and external respiratory function in MDR pulmonary TB patients with broncho-obstructive syndrome (BOS) Source: Annual Congress 2012 - New insights in the clinical management of lung diseases Year: 2012 Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Small airway abnormalities in elderly asthmatics with fixed airflow obstruction vs. COPD: High-resolution CT and pulmonary functions Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Rapid onset bronchodilation with formoterol or salbutamol in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 514s Year: 2001